(POLYG) Polygiene - Ratings and Ratios

Exchange: ST • Country: Sweden • Currency: SEK • Type: Common Stock • ISIN: SE0007692157

POLYG: Antimicrobial, Textiles, Surfaces, OdorControl, ViralPrevention

Polygiene Group AB (ST:POLYG) is a global leader in antimicrobial solutions, specializing in treatments for textiles and hard surfaces. The company operates through two primary segments: Polygiene and Addmaster, offering advanced technologies such as OdorCrunch, StayFresh, ScentMaster, ViralOff, BioMaster, and VeriMaster. These solutions are integrated into products across diverse industries, including sports and outdoor, fashion and lifestyle, workwear, hospitality, healthcare, and industrial applications. Headquartered in Malmö, Sweden, Polygiene Group AB was founded in 2005 and rebranded from Polygiene AB (publ.) in June 2022. The company serves partners worldwide, enhancing product performance and durability through its innovative antimicrobial treatments.

As of the latest data, Polygiene Group ABs stock is trading at 11.95 SEK with an average 20-day volume of 17,737 shares. The stocks short-term moving averages (SMA 20 and SMA 50) are currently above the last price, at 12.46 and 12.93, respectively, while the SMA 200 stands at 10.98. The Average True Range (ATR) is 0.96, indicating moderate price volatility. The companys market capitalization is 396.32M SEK, with a price-to-book (P/B) ratio of 1.37 and a price-to-sales (P/S) ratio of 2.78. The return on equity (RoE) is reported at 5.46%.

3-Month Forecast: Based on the technical and fundamental data, Polygiene Group ABs stock is expected to experience sideways to slightly bearish movement in the near term. The SMA 20 and SMA 50 are above the current price, suggesting potential resistance levels ahead. The relatively low ATR indicates limited volatility, which may result in a narrow trading range. From a fundamental perspective, the P/B ratio slightly above 1 suggests the stock is fairly valued, while the P/S ratio indicates reasonable pricing relative to its revenue. The RoE of 5.46% reflects moderate profitability but may not drive significant upside momentum. Overall, the stock is likely to remain range-bound with limited upside potential and a possible decline if support levels are breached.

Additional Sources for POLYG Stock

Tweets: X Stocktwits
Fund Manager Positions: Dataroma Stockcircle

POLYG Stock Overview

Market Cap in USD 39m
Sector Basic Materials
Industry Specialty Chemicals
GiC Sub-Industry Specialty Chemicals
IPO / Inception

POLYG Stock Ratings

Growth 5y 6.69%
Fundamental 22.1%
Dividend 0.0%
Rel. Strength 63.4
Analysts -
Fair Price Momentum 9.75 SEK
Fair Price DCF 10.04 SEK

POLYG Dividends

No Dividends Paid

POLYG Growth Ratios

Growth Correlation 3m -94.1%
Growth Correlation 12m 75%
Growth Correlation 5y -62.8%
CAGR 5y 7.38%
CAGR/Max DD 5y 0.08
Sharpe Ratio 12m -1.69
Alpha 41.95
Beta 1.510
Volatility 67.07%
Current Volume 21.4k
Average Volume 20d 5.3k
What is the price of POLYG stocks?
As of April 09, 2025, the stock is trading at SEK 11.00 with a total of 21,426 shares traded.
Over the past week, the price has changed by +15.79%, over one month by +0.46%, over three months by -18.82% and over the past year by +37.50%.
Is Polygiene a good stock to buy?
Neither. Based on ValueRay Fundamental Analyses, Polygiene is currently (April 2025) neither a good nor a bad stock to buy. It has a ValueRay Fundamental Rating of 22.14 and therefor a neutral outlook according to the companies health.
Based on ValueRays Analyses, Dividends and Discounted-Cash-Flow, the Fair Value of POLYG as of April 2025 is 9.75. This means that POLYG is currently overvalued and has a potential downside of -11.36%.
Is POLYG a buy, sell or hold?
Polygiene has no consensus analysts rating.
What are the forecast for POLYG stock price target?
According to ValueRays Forecast Model, POLYG Polygiene will be worth about 11 in April 2026. The stock is currently trading at 11.00. This means that the stock has a potential upside of +0.36%.
Issuer Forecast Upside
Wallstreet Target Price 13 18.2%
Analysts Target Price - -
ValueRay Target Price 11 0.4%